These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 26752148)

  • 1. Distribution of human umbilical cord blood-derived mesenchymal stem cells in the Alzheimer's disease transgenic mouse after a single intravenous injection.
    Park SE; Lee NK; Lee J; Hwang JW; Choi SJ; Hwang H; Hyung B; Chang JW; Na DL
    Neuroreport; 2016 Mar; 27(4):235-41. PubMed ID: 26752148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GDF-15 secreted from human umbilical cord blood mesenchymal stem cells delivered through the cerebrospinal fluid promotes hippocampal neurogenesis and synaptic activity in an Alzheimer's disease model.
    Kim DH; Lee D; Chang EH; Kim JH; Hwang JW; Kim JY; Kyung JW; Kim SH; Oh JS; Shim SM; Na DL; Oh W; Chang JW
    Stem Cells Dev; 2015 Oct; 24(20):2378-90. PubMed ID: 26154268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intra-Arterially Delivered Mesenchymal Stem Cells Are Not Detected in the Brain Parenchyma in an Alzheimer's Disease Mouse Model.
    Lee NK; Yang J; Chang EH; Park SE; Lee J; Choi SJ; Oh W; Chang JW; Na DL
    PLoS One; 2016; 11(5):e0155912. PubMed ID: 27203695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human Umbilical Cord Stem Cell Xenografts Improve Cognitive Decline and Reduce the Amyloid Burden in a Mouse Model of Alzheimer's Disease.
    Boutajangout A; Noorwali A; Atta H; Wisniewski T
    Curr Alzheimer Res; 2017; 14(1):104-111. PubMed ID: 27719629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble intracellular adhesion molecule-1 secreted by human umbilical cord blood-derived mesenchymal stem cell reduces amyloid-β plaques.
    Kim JY; Kim DH; Kim JH; Lee D; Jeon HB; Kwon SJ; Kim SM; Yoo YJ; Lee EH; Choi SJ; Seo SW; Lee JI; Na DL; Yang YS; Oh W; Chang JW
    Cell Death Differ; 2012 Apr; 19(4):680-91. PubMed ID: 22015609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution pattern following systemic mesenchymal stem cell injection depends on the age of the recipient and neuronal health.
    Fabian C; Naaldijk Y; Leovsky C; Johnson AA; Rudolph L; Jaeger C; Arnold K; Stolzing A
    Stem Cell Res Ther; 2017 Apr; 8(1):85. PubMed ID: 28420415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The therapeutic potential of human umbilical cord blood-derived mesenchymal stem cells in Alzheimer's disease.
    Lee HJ; Lee JK; Lee H; Shin JW; Carter JE; Sakamoto T; Jin HK; Bae JS
    Neurosci Lett; 2010 Aug; 481(1):30-5. PubMed ID: 20600610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intranasal delivery of bone marrow-derived mesenchymal stem cells, macrophages, and microglia to the brain in mouse models of Alzheimer's and Parkinson's disease.
    Danielyan L; Beer-Hammer S; Stolzing A; Schäfer R; Siegel G; Fabian C; Kahle P; Biedermann T; Lourhmati A; Buadze M; Novakovic A; Proksch B; Gleiter CH; Frey WH; Schwab M
    Cell Transplant; 2014; 23 Suppl 1():S123-39. PubMed ID: 25302802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution of human umbilical cord blood-derived mesenchymal stem cells (hUCB-MSCs) in canines after intracerebroventricular injection.
    Park SE; Jung NY; Lee NK; Lee J; Hyung B; Myeong SH; Kim HS; Suh YL; Lee JI; Cho KR; Kim DH; Choi SJ; Chang JW; Na DL
    Neurobiol Aging; 2016 Nov; 47():192-200. PubMed ID: 27614113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Administrations of human adult ischemia-tolerant mesenchymal stem cells and factors reduce amyloid beta pathology in a mouse model of Alzheimer's disease.
    Harach T; Jammes F; Muller C; Duthilleul N; Cheatham V; Zufferey V; Cheatham D; Lukasheva YA; Lasser T; Bolmont T
    Neurobiol Aging; 2017 Mar; 51():83-96. PubMed ID: 28056358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human umbilical cord blood-derived mesenchymal stem cells improve neuropathology and cognitive impairment in an Alzheimer's disease mouse model through modulation of neuroinflammation.
    Lee HJ; Lee JK; Lee H; Carter JE; Chang JW; Oh W; Yang YS; Suh JG; Lee BH; Jin HK; Bae JS
    Neurobiol Aging; 2012 Mar; 33(3):588-602. PubMed ID: 20471717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human umbilical cord blood-derived mesenchymal stem cells improve functional recovery through thrombospondin1, pantraxin3, and vascular endothelial growth factor in the ischemic rat brain.
    Park HW; Moon HE; Kim HS; Paek SL; Kim Y; Chang JW; Yang YS; Kim K; Oh W; Hwang JH; Kim JW; Kim DG; Paek SH
    J Neurosci Res; 2015 Dec; 93(12):1814-25. PubMed ID: 26332684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro validation of effects of BDNF-expressing mesenchymal stem cells on neurodegeneration in primary cultured neurons of APP/PS1 mice.
    Song MS; Learman CR; Ahn KC; Baker GB; Kippe J; Field EM; Dunbar GL
    Neuroscience; 2015 Oct; 307():37-50. PubMed ID: 26297896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracerebral transplantation of adipose-derived mesenchymal stem cells alternatively activates microglia and ameliorates neuropathological deficits in Alzheimer's disease mice.
    Ma T; Gong K; Ao Q; Yan Y; Song B; Huang H; Zhang X; Gong Y
    Cell Transplant; 2013; 22 Suppl 1():S113-26. PubMed ID: 24070198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracerebral transplantation of bone marrow-derived mesenchymal stem cells reduces amyloid-beta deposition and rescues memory deficits in Alzheimer's disease mice by modulation of immune responses.
    Lee JK; Jin HK; Endo S; Schuchman EH; Carter JE; Bae JS
    Stem Cells; 2010 Feb; 28(2):329-43. PubMed ID: 20014009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimization of the therapeutic efficacy of human umbilical cord blood-mesenchymal stromal cells in an NSG mouse xenograft model of graft-versus-host disease.
    Jang YK; Kim M; Lee YH; Oh W; Yang YS; Choi SJ
    Cytotherapy; 2014 Mar; 16(3):298-308. PubMed ID: 24418403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low immunogenicity of allogeneic human umbilical cord blood-derived mesenchymal stem cells in vitro and in vivo.
    Lee M; Jeong SY; Ha J; Kim M; Jin HJ; Kwon SJ; Chang JW; Choi SJ; Oh W; Yang YS; Kim JS; Jeon HB
    Biochem Biophys Res Commun; 2014 Apr; 446(4):983-9. PubMed ID: 24657442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone marrow-derived mesenchymal stem cells contribute to the reduction of amyloid-β deposits and the improvement of synaptic transmission in a mouse model of pre-dementia Alzheimer's disease.
    Bae JS; Jin HK; Lee JK; Richardson JC; Carter JE
    Curr Alzheimer Res; 2013 Jun; 10(5):524-31. PubMed ID: 23036020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesenchymal Stem Cells as Treatment for Behavioral Deficits and Neuropathology in the 5xFAD Mouse Model of Alzheimer's Disease.
    Matchynski-Franks JJ; Pappas C; Rossignol J; Reinke T; Fink K; Crane A; Twite A; Lowrance SA; Song C; Dunbar GL
    Cell Transplant; 2016; 25(4):687-703. PubMed ID: 26850119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human umbilical cord blood mesenchymal stem cells reduce colitis in mice by activating NOD2 signaling to COX2.
    Kim HS; Shin TH; Lee BC; Yu KR; Seo Y; Lee S; Seo MS; Hong IS; Choi SW; Seo KW; Núñez G; Park JH; Kang KS
    Gastroenterology; 2013 Dec; 145(6):1392-403.e1-8. PubMed ID: 23973922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.